US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Arch Biopartners Inc.

0.6425

-0.0410-6.00%

Volume:64.18K

Turnover:41.66K

Market Cap:43.01M

PE:-37.81

High:0.7053

Open:0.7053

Low:0.6070

Close:0.6835

52wk High:1.42

52wk Low:0.5178

Shares:66.93M

Float Shares:50.06M

Volume Ratio:0.66

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0170

EPS(LYR):-0.0434

ROE:142.78%

ROA:-136.33%

PB:-15.13

PE(LYR):-14.81

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Arch Biopartners Inc.

Exchange:

OTCQB

Establishment Date:

- -

Employees:

- -

Office Location:

545 King Street West,Toronto,Ontario,Canada

Website:

http://www.archbiopartners.com

Zip Code:

M5V 1M1

Phone:

Fax:

- -

Introduction:

Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug candidate LSALT Peptide, a product in Phase 2 clinical trials to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys. The company also develops AB569 for treating antibiotic-resistant bacterial infections, and for the treatment of wounds; and Borg, a peptide-solid surface interface to reduce corrosion of metals. Arch Biopartners Inc. is based in Toronto, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACHFF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ACHFF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACHFF\",,,,,undefined,":{"symbol":"ACHFF","market":"US","secType":"STK","nameCN":"Arch Biopartners Inc.","latestPrice":0.64252,"timestamp":1771362000000,"preClose":0.6835,"halted":0,"volume":64176,"delay":15,"changeRate":-0.059956108266276543,"floatShares":50064327,"shares":66933289,"eps":-0.016992,"marketStatus":"Closed","change":-0.04098,"latestTime":"02-17 16:00:00 EST Delay","open":0.7053,"high":0.7053,"low":0.607,"amount":41657.03185,"amplitude":0.143819,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.016992,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771405200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.6835,"volumeRatio":0.659795},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACHFF\",,,,,undefined,":{"symbol":"ACHFF","floatShares":50064327,"roa":"-136.33%","roe":"142.78%","lyrEps":-0.043386,"volumeRatio":0.659795,"shares":66933289,"dividePrice":0,"high":0.7053,"amplitude":0.143819,"preClose":0.6835,"low":0.607,"week52Low":0.517805,"pbRate":"-15.13","psRate":"212.78","week52High":1.415,"institutionHeld":0,"latestPrice":0.64252,"eps":-0.016992,"divideRate":0,"volume":64176,"delay":15,"ttmEps":-0.016992,"open":0.7053,"prevYearClose":0.8834,"prevWeekClose":0.6835,"prevMonthClose":0.765,"prevQuarterClose":0.8834,"fiveDayClose":0.5787,"twentyDayClose":0.9904,"sixtyDayClose":0.727},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACHFF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-29","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724904000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-30","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1717041600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-28","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-01-29","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1706504400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-29","symbol":"ACHFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1693281600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACHFF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACHFF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":30514493,"address":"545 King Street West,Toronto,Ontario,Canada","zipCode":"M5V 1M1","officePhone":"647-428-7031"},"stockCompanyDetail":{"websiteUrl":"http://www.archbiopartners.com","stockEarnings":[{"period":"1week","weight":0.0232},{"period":"1month","weight":-0.0436},{"period":"3month","weight":-0.1573},{"period":"6month","weight":-0.1279},{"period":"1year","weight":-0.3582},{"period":"ytd","weight":-0.1657}],"description":"Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug candidate LSALT Peptide, a product in Phase 2 clinical trials to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys. The company also develops AB569 for treating antibiotic-resistant bacterial infections, and for the treatment of wounds; and Borg, a peptide-solid surface interface to reduce corrosion of metals. Arch Biopartners Inc. is based in Toronto, Canada.","exchange":"OTCQB","name":"Arch Biopartners Inc.","nameEN":"Arch Biopartners Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACHFF\",market:\"US\",,,undefined,":null}}